Overview

Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a double blinded, randomised, crossover study with 12 healthy men between 18 and 40 year. The design is based on 6 days: - day 1: On day time administration of LPS. - day 2: On night time administration of LPS. - day 3: On day time administration of LPS + Placebo. - day 4: On day time administration of LPS + melatonin. - day 5: On night time administration of LPS + placebo. - day 6: On night time administration og LPS + melatonin. Measuring the inflammatoric and oxidative response of LPS and the effect of melatonin compared to placebo on the endotoxaemia.
Phase:
Phase 4
Details
Lead Sponsor:
Herlev Hospital
Treatments:
Melatonin